Lars Uhlin‐Hansen

3.0k total citations
56 papers, 2.5k citations indexed

About

Lars Uhlin‐Hansen is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Lars Uhlin‐Hansen has authored 56 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 23 papers in Oncology and 21 papers in Cell Biology. Recurrent topics in Lars Uhlin‐Hansen's work include Proteoglycans and glycosaminoglycans research (21 papers), Protease and Inhibitor Mechanisms (18 papers) and Peptidase Inhibition and Analysis (14 papers). Lars Uhlin‐Hansen is often cited by papers focused on Proteoglycans and glycosaminoglycans research (21 papers), Protease and Inhibitor Mechanisms (18 papers) and Peptidase Inhibition and Analysis (14 papers). Lars Uhlin‐Hansen collaborates with scholars based in Norway, United States and Finland. Lars Uhlin‐Hansen's co-authors include Jan‐Olof Winberg, Elin Hadler‐Olsen, Eli Berg, Svein O. Kolset, Sonja E. Steigen, Ingebrigt Sylte, Øystein Rekdal, Oddveig Rikardsen, S. O. Kolset and Masaki Yanagishita and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and The Journal of Experimental Medicine.

In The Last Decade

Lars Uhlin‐Hansen

56 papers receiving 2.4k citations

Peers

Countries citing papers authored by Lars Uhlin‐Hansen

Since Specialization

Citations

This map shows the geographic impact of Lars Uhlin‐Hansen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Uhlin‐Hansen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Uhlin‐Hansen more than expected).

Fields of papers citing papers by Lars Uhlin‐Hansen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lars Uhlin‐Hansen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Uhlin‐Hansen. The network helps show where Lars Uhlin‐Hansen may publish in the future.

Co-authorship network of co-authors of Lars Uhlin‐Hansen

This figure shows the co-authorship network connecting the top 25 collaborators of Lars Uhlin‐Hansen. A scholar is included among the top collaborators of Lars Uhlin‐Hansen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lars Uhlin‐Hansen. Lars Uhlin‐Hansen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Loss of S100A14 expression at the tumor‐invading front correlates with poor differentiation and worse prognosis in oral squamous cell carcinoma 2020 ·Head & Neck ·(unknown), Tarig Osman, (unknown), (unknown), Aboulghassem Shahdadfar, (unknown), (unknown), Lars Uhlin‐Hansen, Oddveig Rikardsen, Anne Christine Johannessen, Daniela Elena Costea, Dipak Sapkota	10
2	Tumor budding score predicts lymph node status in oral tongue squamous cell carcinoma and should be included in the pathology report 2020 ·PLoS ONE ·(unknown), (unknown), (unknown), Tine M. Søland, Daniela Elena Costea, (unknown), Lars Uhlin‐Hansen, Elin Hadler‐Olsen, Sonja E. Steigen	31
3	Presence of high-endothelial venules correlates with a favorable immune microenvironment in oral squamous cell carcinoma 2018 ·Modern Pathology ·Anna Maria Wirsing, (unknown), Marit Seppola, Lars Uhlin‐Hansen, Sonja E. Steigen, Elin Hadler‐Olsen	76
4	Plectin as a prognostic marker in non-metastatic oral squamous cell carcinoma 2015 ·BMC Oral Health ·Oddveig Rikardsen, (unknown), Gunbjørg Svineng, Elin Hadler‐Olsen, Lars Uhlin‐Hansen, Sonja E. Steigen	14
5	Small lytic peptides escape the inhibitory effect of heparan sulfate on the surface of cancer cells 2011 ·BMC Cancer ·(unknown), Lars Uhlin‐Hansen, (unknown), Øystein Rekdal	41
6	S100A4 Expression in Xenograft Tumors of Human Carcinoma Cell Lines Is Induced by the Tumor Microenvironment 2011 ·American Journal Of Pathology ·(unknown), Elin Hadler‐Olsen, (unknown), Oddveig Rikardsen, Sonja E. Steigen, (unknown), Thrina Loennechen, Premasany Kanapathippillai, (unknown), Jan‐Olof Winberg, Lars Uhlin‐Hansen, Gunbjørg Svineng	6
7	Biosynthesis of Promatrix Metalloproteinase-9/Chondroitin Sulphate Proteoglycan Heteromer Involves a Rottlerin-Sensitive Pathway 2011 ·PLoS ONE ·(unknown), Eli Berg, Ugo Moens, Lars Uhlin‐Hansen, Jan‐Olof Winberg	6
8	Regulation of matrix metalloproteinase activity in health and disease 2010 ·FEBS Journal ·Elin Hadler‐Olsen, (unknown), Ingebrigt Sylte, Lars Uhlin‐Hansen, Jan‐Olof Winberg	298
9	Stromal impact on tumor growth and lymphangiogenesis in human carcinoma xenografts 2010 ·Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin ·Elin Hadler‐Olsen, (unknown), Oddveig Rikardsen, Sonja E. Steigen, Premasany Kanapathippillai, Reidar Grénman, Jan‐Olof Winberg, Gunbjørg Svineng, Lars Uhlin‐Hansen	12
10	The anticancer activity of lytic peptides is inhibited by heparan sulfate on the surface of the tumor cells 2009 ·BMC Cancer ·(unknown), Øystein Rekdal, Lars Uhlin‐Hansen	50
11	Interaction of Pro-matrix Metalloproteinase-9/Proteoglycan Heteromer with Gelatin and Collagen 2008 ·Journal of Biological Chemistry ·(unknown), Eli Berg, Lars Uhlin‐Hansen, Jan‐Olof Winberg	28
12	Anti-HSV activity of lactoferricin analogues is only partly related to their affinity for heparan sulfate 2003 ·Antiviral Research ·Håvard Jenssen, Jeanette H. Andersen, Lars Uhlin‐Hansen, Tore Jarl Gutteberg, Øystein Rekdal	86
13	Secretion of macrophage urokinase plasminogen activator is dependent on proteoglycans 2003 ·European Journal of Biochemistry ·Gunnar Pejler, Jan‐Olof Winberg, Tram Thu Vuong, Frida Henningsson, Lars Uhlin‐Hansen, Koji Kimata, Svein O. Kolset	12
14	Calcium‐induced activation and truncation of promatrix metalloproteinase‐9 linked to the core protein of chondroitin sulfate proteoglycans 2003 ·European Journal of Biochemistry ·Jan‐Olof Winberg, Eli Berg, Svein O. Kolset, Lars Uhlin‐Hansen	47
15	C-reactive protein (CRP), a comparison of pre- and post-mortem blood levels 2001 ·Forensic Science International ·Lars Uhlin‐Hansen	34
16	Serglycin expression during monocytic differentiation of U937-1 cells 1998 ·Glycobiology ·Mari Ann Kulseth, (unknown), Lars Uhlin‐Hansen, Fredrik Öberg, Svein O. Kolset	14
17	Mouse Mastocytoma Cells Synthesize Undersulfated Heparin and Chondroitin Sulfate in the Presence of Brefeldin A 1997 ·Journal of Biological Chemistry ·Lars Uhlin‐Hansen, Marion Kusche‐Gullberg, Eli Berg, Inger Eriksson, Lena Kjellén	12
18	Brefeldin A inhibits the endocytosis of plasma-membrane-associated heparan sulphate proteoglycans of cultured rat ovarian granulosa cells 1995 ·Biochemical Journal ·Lars Uhlin‐Hansen, Masaki Yanagishita	13
19	Antibody‐Mediated enhancement of BK virus infection in human monocytes and a human macrophage‐like cell line 1988 ·Journal of Medical Virology ·Terje Traavik, Lars Uhlin‐Hansen, Trond Flægstad, K. E. Christie	14
20	Proteoglycan biosynthesis in relation to differentiation of cord blood monocytes in vitro 1987 ·Cell Differentiation ·Lars Uhlin‐Hansen, Svein O. Kolset	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact